neuromuscular disease |
Disease ID | 646 |
---|---|
Disease | neuromuscular disease |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:10) C0004093 | weakness | 7 C0015672 | fatigue | 5 C1145670 | respiratory failure | 5 C0036439 | scoliosis | 4 C0020440 | hypercapnia | 2 C0948265 | metabolic syndrome | 2 C0264490 | acute respiratory failure | 2 C0264492 | chronic respiratory failure | 2 C0851578 | sleep disorders | 1 C0026846 | muscle wasting | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:23) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs104894351 | 16949546 | 26353 | HSPB8 | umls:C0027868 | BeFree | Structure and properties of K141E mutant of small heat shock protein HSP22 (HspB8, H11) that is expressed in human neuromuscular disorders. | 0.000542884 | 2006 | HSPB8 | 12 | 119187078 | A | G |
rs121912633 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109792396 | C | T |
rs121912637 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109784378 | G | C,A |
rs187864727 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109803054 | C | A,T |
rs207482230 | 25725944 | 10342 | TFG | umls:C0027868 | BeFree | Here, genome-wide linkage analysis and exome sequencing in an Iranian pedigree with 16 members affected with a neuromuscular disease led to identification of a mutation in TFG that causes p.Pro285Leu as cause of disease. | 0.000271442 | 2014 | TFG | 3 | 100748182 | C | T |
rs267607143 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109798823 | G | A |
rs267607144 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109800665 | C | T |
rs267607145 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109798820 | G | A |
rs267607146 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109800666 | G | A |
rs267607148 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109800639 | C | T |
rs267607149 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109784385 | C | T |
rs387906902 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109793560 | G | T |
rs387906904 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109803009 | G | A |
rs387906905 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109798819 | C | T |
rs387906906 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109786827 | G | A |
rs387906907 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109800645 | T | C |
rs397514474 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109814565 | C | A |
rs397514494 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109808298 | C | T |
rs515726157 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109792704 | T | C |
rs515726166 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109784362 | GGTCTCATTCTTGCCCG | - |
rs74521370 | 22927026 | 126306 | JSRP1 | umls:C0027868 | BeFree | Two JSRP1 variants have been found in the human population: c.323C>T (p.P108L) in exon 5 and c.449G>C (p.G150A) in exon 6, but nothing is known concerning the incidence of these polymorphisms in the general population or in patients with neuromuscular diseases nor the impact of the polymorphisms on excitation-contraction (EC) coupling. | 0.000271442 | 2013 | JSRP1 | 19 | 2253733 | G | A |
rs77975504 | NA | 59341 | TRPV4 | umls:C0027868 | CLINVAR | NA | 0.120542884 | NA | TRPV4 | 12 | 109792695 | C | T |
rs80043033 | 22927026 | 126306 | JSRP1 | umls:C0027868 | BeFree | Two JSRP1 variants have been found in the human population: c.323C>T (p.P108L) in exon 5 and c.449G>C (p.G150A) in exon 6, but nothing is known concerning the incidence of these polymorphisms in the general population or in patients with neuromuscular diseases nor the impact of the polymorphisms on excitation-contraction (EC) coupling. | 0.000271442 | 2013 | JSRP1 | 19 | 2252991 | C | G |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:16) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0027868 | amlodipine | D017311 | 88150-42-9 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 9825082 | ||
C0027868 | amodiaquine | D000655 | 86-42-0 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 3651930 | ||
C0027868 | azacitidine | D001374 | 320-67-2 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 6178065 | ||
C0027868 | chloroquine | D002738 | 1954/5/7 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 10686640 | ||
C0027868 | cimetidine | D002927 | 51481-61-9 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 3010423 | ||
C0027868 | colchicine | D003078 | 64-86-8 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 10686640 | ||
C0027868 | cyclophosphamide | D003520 | 50-18-0 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 278643 | ||
C0027868 | cyclosporine | D016572 | 59865-13-3 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 12122515 | ||
C0027868 | dapsone | D003622 | 80-08-0 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 182085 | ||
C0027868 | cisplatin | D002945 | 15663-27-1 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 7692001 | ||
C0027868 | disopyramide | D004206 | 3737/9/5 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 2564745 | ||
C0027868 | omeprazole | D009853 | 73590-58-6 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 9466609 | ||
C0027868 | paclitaxel | D017239 | - | neuromuscular diseases | MESH:D009468 | marker/mechanism | 7692001 | ||
C0027868 | phenytoin | D010672 | 57-41-0 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 19302663 | ||
C0027868 | quinine | D011803 | 130-95-0 | neuromuscular diseases | MESH:D009468 | marker/mechanism | 16568672 | ||
C0027868 | vincristine | D014750 | - | neuromuscular diseases | MESH:D009468 | marker/mechanism | 278643 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |